<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35586678</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2468-4287</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>8</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of vascular surgery cases and innovative techniques</Title>
          <ISOAbbreviation>J Vasc Surg Cases Innov Tech</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A case of IgG4-related retroperitoneal fibrosis with significant involvement of the abdominal aorta-a clinical and diagnostic challenge.</ArticleTitle>
        <Pagination>
          <StartPage>275</StartPage>
          <EndPage>280</EndPage>
          <MedlinePgn>275-280</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvscit.2022.02.003</ELocationID>
        <Abstract>
          <AbstractText>Immunoglobulin (Ig)G4-related disease (IgG4-RD) with retroperitoneal fibrosis (RPF) is a rare, fibroinflammatory disease involving the soft tissues of the retroperitoneum. A 73-year-old man with IgG4-related RPF affecting the abdominal aorta and iliac arteries was treated with steroids and mycophenolate mofetil. The prevalence of the disease remains unknown because it is often misdiagnosed and can mimic many malignant, infectious, and inflammatory conditions. Autoimmune pancreatitis is a common presenting condition of IgG4-RD. Because As IgG4-RD is responsive to steroids, diagnosing IgG4-related RPF early can prevent the exposure of patients with RPF to unnecessary diagnostic and therapeutic interventions.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gormley</LastName>
            <ForeName>Sinead</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Vascular and Endovascular Surgery, Waikato Hospital, Hamilton, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bravo</LastName>
            <ForeName>Paola Tacuri</ForeName>
            <Initials>PT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Histology, Waikato Hospital, Hamilton, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kos</LastName>
            <ForeName>Xavier</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Interventional Radiology, Waikato Hospital, Hamilton, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Solanki</LastName>
            <ForeName>Kamal</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Waikato Hospital, Hamilton, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khashram</LastName>
            <ForeName>Manar</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Vascular and Endovascular Surgery, Waikato Hospital, Hamilton, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Vasc Surg Cases Innov Tech</MedlineTA>
        <NlmUniqueID>101701125</NlmUniqueID>
        <ISSNLinking>2468-4287</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Abdominal aorta</Keyword>
        <Keyword MajorTopicYN="N">Case report</Keyword>
        <Keyword MajorTopicYN="N">IgG4-related disease</Keyword>
        <Keyword MajorTopicYN="N">Pancreatitis</Keyword>
        <Keyword MajorTopicYN="N">Retroperitoneal fibrosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>2</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35586678</ArticleId>
        <ArticleId IdType="pmc">PMC9108322</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jvscit.2022.02.003</ArticleId>
        <ArticleId IdType="pii">S2468-4287(22)00022-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Tanaka T., Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis. Int J Urol. 2020;27:387–394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32166828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11236777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cronin C.G., Lohan D.G., Blake M.A., Roche C., McCarthy P., Murphy J.M. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol. 2008;191:423–431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18647912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lian L., Wang C., Tian J.-L. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis. 2016;19:1049–1055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27125330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Umehara H., Okazaki K., Masaki Y., Kawano M., Yamamoto M., Saeki T., et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22218969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pucar D., Hinchcliff M. FDG PET vascular imaging in IgG4-RD: potential and challenges. J Nucl Cardiol. 2021 doi: 10.1007/s12350-021-02887-1. Accessed February 1, 2022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12350-021-02887-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khosroshahi A., Wallace Z.S., Crowe J.L., Akamizu T., Azumi A., Carruthers M.N., et al.  International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688–1699.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25809420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mota M.M.D.S., Bezerra R.O.F., Garcia M.R.T. Practical approach to primary retroperitoneal masses in adults. Radiol Bras. 2018;51:391–400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6290739</ArticleId>
            <ArticleId IdType="pubmed">30559557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almeqdadi M., Al-Dulaimi M., Perepletchikov A., Tomera K., Jaber B.L. Rituximab for retroperitoneal fibrosis due to IgG4-related disease: a case report and literature review. Clin Nephrol Case Stud. 2018;6:4–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5933309</ArticleId>
            <ArticleId IdType="pubmed">29845002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caiafa R.O., Vinuesa A.S., Izquierdo R.S., Brufau B.P., Colella J.R.A., Molina C.N. Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics. 2013;33:535–552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23479712</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
